Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision updated to v3.5.2 (replacing v3.5.0).SummaryDifference0.0%

- Check51 days agoChange DetectedStatus updated from Active, not recruiting to Completed with completion date 2026-02-12, and page revision updated to Revision: v3.5.0.SummaryDifference0.3%

- Check58 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This is a minor update with no changes to essential study information.SummaryDifference0.0%

- Check80 days agoChange DetectedRemoved the lay language results summary, sponsor attribution (Ipsen), and the 'Helpful Links Provided by' section from the Study Details page.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded a new site revision tag (v3.4.2) and removed an older government-funding notice and the previous revision tag (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.